Biofrontera (BFRI) AGM 2026 summary

Opening remarks and agenda

• Meeting formally called to order with directors and key executives introduced via remote communication.

• Agenda and rules of conduct made available to attendees; meeting recording restricted to company only.

Board and executive committee updates

• Directors in attendance included John Borer, Beth Hoffman, and Heikki Lanckriet.

• Key executives present: CEO, CFO, Chief Commercial Officer, legal counsel, and Inspector of Elections.

Shareholder proposals

• Three proposals presented: election of two Class II directors, amendment of the 2021 Omnibus Incentive Plan, and ratification of the independent auditor.